scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10792-018-0843-0 |
P698 | PubMed publication ID | 29549486 |
P2093 | author name string | Harminder S Dua | |
Marco Messina | |||
P2860 | cites work | A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome. | Q50702654 |
Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) | Q80347919 | ||
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure | Q26764956 | ||
The role of the lacrimal functional unit in the pathophysiology of dry eye. | Q35755146 | ||
Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine | Q36269034 | ||
Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion | Q36640556 | ||
Dry Eye Disease: Present Challenges in the Management and Future Trends | Q38853787 | ||
Predictors of Discordance between Symptoms and Signs in Dry Eye Disease | Q40407061 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 693-696 | |
P577 | publication date | 2018-03-16 | |
P1433 | published in | International Ophthalmology | Q15763839 |
P1476 | title | Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology | |
P478 | volume | 39 |
Search more.